Netanel A. Horowitz

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 236 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study

Anas Younes, Joshua Brody, Cecilia Carpio et al. · The Lancet Haematology · 2019 · 195 citations · Full text

Life Sciences, Immunology, Oncology +15

Colitis-Associated Cancer Is Dependent on the Interplay between the Hemostatic and Inflammatory Systems and Supported by Integrin αMβ2 Engagement of Fibrinogen

Kris A. Steinbrecher, Netanel A. Horowitz, Elizabeth A. Blevins et al. · Cancer Research · 2010 · 168 citations · Full text

Medicine, Cancer Biology, Oncology +17

Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis

Marina Weissmann, Gil Arvatz, Netanel A. Horowitz et al. · Proceedings of the National Academy of Sciences · 2016 · 115 citations · Full text

Medicine, Cancer Biology, Oncology +17